Published in Neurotox Res on November 24, 2009
Environmental toxicants and autism spectrum disorders: a systematic review. Transl Psychiatry (2014) 1.30
Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment. Neurotoxicol Teratol (2012) 1.21
Toxic element contamination of natural health products and pharmaceutical preparations. PLoS One (2012) 0.95
Correlations of gene expression with blood lead levels in children with autism compared to typically developing controls. Neurotox Res (2009) 0.93
Atypical miRNA expression in temporal cortex associated with dysregulation of immune, cell cycle, and other pathways in autism spectrum disorders. Mol Autism (2015) 0.86
Role of metabolic genes in blood arsenic concentrations of Jamaican children with and without autism spectrum disorder. Int J Environ Res Public Health (2014) 0.83
Lack of association between autism and four heavy metal regulatory genes. Neurotoxicology (2011) 0.81
Potential Role of Selenoenzymes and Antioxidant Metabolism in relation to Autism Etiology and Pathology. Autism Res Treat (2014) 0.77
Chemicals, Nutrition, and Autism Spectrum Disorder: A Mini-Review. Front Neurosci (2016) 0.77
Blood transcriptomic comparison of individuals with and without autism spectrum disorder: A combined-samples mega-analysis. Am J Med Genet B Neuropsychiatr Genet (2016) 0.76
Relationship between selenium, lead, and mercury in red blood cells of Saudi autistic children. Metab Brain Dis (2017) 0.76
Variation in Gene Expression in Autism Spectrum Disorders: An Extensive Review of Transcriptomic Studies. Front Neurosci (2017) 0.75
Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord (1994) 42.80
The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol (1996) 22.30
The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol (2008) 20.89
An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science (1996) 13.87
Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene (1999) 13.46
Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science (1999) 11.96
Transcriptional control by the TGF-beta/Smad signaling system. EMBO J (2000) 8.49
Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell (1994) 7.23
The toxicology of mercury and its chemical compounds. Crit Rev Toxicol (2006) 5.76
Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature (1994) 5.58
Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature (2001) 4.96
Redefining oxidative stress. Antioxid Redox Signal (2006) 4.71
Preprocessing of oligonucleotide array data. Nat Biotechnol (2004) 4.70
The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol (1993) 4.35
Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature (2000) 4.30
The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect (2006) 3.81
Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem (2001) 3.50
Diagnosing autism: analyses of data from the Autism Diagnostic Interview. J Autism Dev Disord (1997) 3.45
The three modern faces of mercury. Environ Health Perspect (2002) 3.33
Migfilin and Mig-2 link focal adhesions to filamin and the actin cytoskeleton and function in cell shape modulation. Cell (2003) 3.19
Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins. Immunity (1995) 3.07
Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med (1999) 2.84
Mercury exposure in children: a review. Toxicol Appl Pharmacol (2004) 2.68
The immune response in autism: a new frontier for autism research. J Leukoc Biol (2006) 2.65
Neurotrophins and netrins require calcineurin/NFAT signaling to stimulate outgrowth of embryonic axons. Cell (2003) 2.54
Hair mercury levels in U.S. children and women of childbearing age: reference range data from NHANES 1999-2000. Environ Health Perspect (2004) 2.35
Signaling inputs converge on nuclear effectors in TGF-beta signaling. Trends Biochem Sci (2000) 2.24
Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism. FASEB J (2009) 1.89
Regulation of Smad signalling by protein associations and signalling crosstalk. Trends Cell Biol (1999) 1.87
The assumptions underlying the analysis of variance. Biometrics (1947) 1.85
A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis. Proc Natl Acad Sci U S A (1995) 1.82
WNT-3, expressed by motoneurons, regulates terminal arborization of neurotrophin-3-responsive spinal sensory neurons. Neuron (2002) 1.81
Technical report: mercury in the environment: implications for pediatricians. Pediatrics (2001) 1.80
Environmental exposure to mercury and its toxicopathologic implications for public health. Environ Toxicol (2003) 1.80
Low dose mercury toxicity and human health. Environ Toxicol Pharmacol (2005) 1.76
Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. J Biol Chem (1999) 1.72
Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins. J Biol Chem (1997) 1.58
Methylmercury and nutrition: adult effects of fetal exposure in experimental models. Neurotoxicology (2008) 1.57
Extracellular redox state: refining the definition of oxidative stress in aging. Rejuvenation Res (2006) 1.55
Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci (1995) 1.52
Fas-associated factor-1 inhibits nuclear factor-kappaB (NF-kappaB) activity by interfering with nuclear translocation of the RelA (p65) subunit of NF-kappaB. J Biol Chem (2003) 1.44
Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environ Health Perspect (2005) 1.42
Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. J Neuroimmunol (2008) 1.41
Cysteine metabolism and metal toxicity. Altern Med Rev (1998) 1.38
The environment as an etiologic factor in autism: a new direction for research. Environ Health Perspect (2000) 1.37
Brain-derived neurotrophic factor activation of NFAT (nuclear factor of activated T-cells)-dependent transcription: a role for the transcription factor NFATc4 in neurotrophin-mediated gene expression. J Neurosci (2003) 1.34
BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci (2000) 1.32
Global transcriptome and deletome profiles of yeast exposed to transition metals. PLoS Genet (2008) 1.23
Proapoptotic BH3-only protein Bim is essential for developmentally programmed death of germinal center-derived memory B cells and antibody-forming cells. Blood (2007) 1.21
The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular and antigenic properties. J Immunol (1997) 1.21
Molecular mechanisms triggered by mercury. Toxicology (2007) 1.18
A novel human actin-binding protein homologue that binds to platelet glycoprotein Ibalpha. Blood (1998) 1.16
Prevalence of serum antibodies to caudate nucleus in autistic children. Neurosci Lett (2004) 1.14
From molecules to mammals: what's NOS got to do with it? Acta Physiol Scand (2003) 1.13
Dysregulated immune system in children with autism: beneficial effects of intravenous immune globulin on autistic characteristics. J Autism Dev Disord (1996) 1.11
Transcriptional activation of the human inducible nitric-oxide synthase promoter by Kruppel-like factor 6. J Biol Chem (2003) 1.11
Differential regulation of glutamate-cysteine ligase subunit expression and increased holoenzyme formation in response to cysteine deprivation. Biochem J (2006) 1.07
Glutamate-cysteine ligase attenuates TNF-induced mitochondrial injury and apoptosis. Free Radic Biol Med (2004) 1.05
Mutations in the Fas antigen gene in lpr mice. Semin Immunol (1994) 1.05
Loss of Bim allows precursor B cell survival but not precursor B cell differentiation in the absence of interleukin 7. J Exp Med (2004) 1.04
PSA-NCAM in postnatally generated immature neurons of the olfactory bulb: a crucial role in regulating p75 expression and cell survival. Development (2007) 1.03
Biology and clinical relevance of granulysin. Tissue Antigens (2009) 1.03
Induction of apoptosis in human T-cells by methyl mercury: temporal relationship between mitochondrial dysfunction and loss of reductive reserve. Toxicol Appl Pharmacol (1999) 1.01
Effects of mercury on the immune system. Met Ions Biol Syst (1997) 1.00
Blood mercury concentrations in CHARGE Study children with and without autism. Environ Health Perspect (2010) 0.98
Omega-3 polyunsaturated fatty acid regulation of gene expression. Curr Opin Lipidol (2000) 0.98
Metallothioneins: mercury species-specific induction and their potential role in attenuating neurotoxicity. Exp Biol Med (Maywood) (2006) 0.96
A novel p75NTR signaling pathway promotes survival, not death, of immunopurified neocortical subplate neurons. J Neurosci (2001) 0.95
Correlations of gene expression with blood lead levels in children with autism compared to typically developing controls. Neurotox Res (2009) 0.93
Immunogenetic studies in autism and related disorders. Mol Chem Neuropathol (1997) 0.92
Proteolytic cleavage of a self-antigen following xenobiotic-induced cell death produces a fragment with novel immunogenic properties. J Immunol (2000) 0.92
Methylmercury-thiol uptake into cultured brain capillary endothelial cells on amino acid system L. J Pharmacol Exp Ther (1995) 0.91
Class II haplotype differentially regulates immune response in HgCl2-treated mice. Clin Immunol Immunopathol (1997) 0.90
Overview of modifiers of methylmercury neurotoxicity: chemicals, nutrients, and the social environment. Neurotoxicology (2008) 0.87
Attenuation of CD95-induced apoptosis by inorganic mercury: caspase-3 is not a direct target of low levels of Hg2+. Toxicol Lett (2005) 0.87
Exposure to inorganic mercury in vivo attenuates extrinsic apoptotic signaling in Staphylococcal aureus enterotoxin B stimulated T-cells. Toxicol Appl Pharmacol (2007) 0.86
Mercury-induced apoptosis in human lymphoid cells: evidence that the apoptotic pathway is mercurial species dependent. Environ Res (2000) 0.86
Early acute necrosis and delayed apoptosis induced by methyl mercury in murine peritoneal neutrophils. Basic Clin Pharmacol Toxicol (2004) 0.85
Brief report: immunoglobulin A deficiency in a subset of autistic subjects. J Autism Dev Disord (1997) 0.85
Resistance to HgCl2-induced autoimmunity in haplotype-heterozygous mice is an intrinsic property of B cells. J Immunol (1998) 0.83
Cloning from the thyroid of a protein related to actin binding protein that is recognized by Graves disease immunoglobulins. Proc Natl Acad Sci U S A (1993) 0.83
Inorganic mercury dissociates preassembled Fas/CD95 receptor oligomers in T lymphocytes. Toxicol Appl Pharmacol (2005) 0.82
Kinetics of methyl mercury in blood and brain during chronic exposure in the monkey Macaca fascicularis. Pharmacol Toxicol (1989) 0.82
Inorganic mercury attenuates CD95-mediated apoptosis by interfering with formation of the death inducing signaling complex. Toxicol Appl Pharmacol (2003) 0.82
The extracellular matrix molecule, laminin, induces purkinje cell dendritic spine proliferation in granule cell depleted cerebellar cultures. Brain Res (1998) 0.81
Molecular markers of heavy metal toxicity--a new paradigm for health risk assessment. J Environ Biol (2008) 0.80
Mercury chloride effects on the function and cellular integrity of sea bass (Dicentrarchus labrax) head kidney macrophages. Fish Shellfish Immunol (2004) 0.79
Mercury intake by inflammatory phagocytes: in vivo cytology of mouse macrophages and neutrophils by X-ray elemental microanalysis coupled with scanning electron microscopy. Hum Exp Toxicol (2004) 0.78
Molecular and cellular mechanisms associated with autoimmune diseases. Int J Environ Res Public Health (2004) 0.78
Microarray analysis of mercury-induced changes in gene expression in human liver carcinoma (HepG2) cells: importance in immune responses. Int J Environ Res Public Health (2006) 0.78
Differential effects of mercury, lead, and cadmium on IL-2 production by Jurkat T cells. Clin Immunol (2004) 0.78
Neonatal tolerance to a Th2-mediated autoimmune disease generates CD8+ Tc1 regulatory cells. J Autoimmun (2003) 0.77
Mercury impairment of mouse thymocyte survival in vitro: involvement of cellular thiols. J Toxicol Environ Health A (2005) 0.77
Acute depletion and recovery of peritoneal B-1 lymphocytes in BALB/c mice after a single injection of mercury chloride. Immunopharmacol Immunotoxicol (2007) 0.76
Review of the toxicity of chemical mixtures: Theory, policy, and regulatory practice. Regul Toxicol Pharmacol (2006) 0.76
Review of the toxicity of chemical mixtures containing at least one organochlorine. Regul Toxicol Pharmacol (2006) 0.76
Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest (2003) 4.06
The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect (2006) 3.81
Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy. Am J Pathol (2006) 3.18
Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism. Epidemiology (2011) 3.15
Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug Alcohol Depend (2004) 2.97
Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab (2009) 2.85
Methods of covariate selection: directed acyclic graphs and the change-in-estimate procedure. Am J Epidemiol (2009) 2.77
The immune response in autism: a new frontier for autism research. J Leukoc Biol (2006) 2.65
Smoking cessation in methadone maintenance. Addiction (2002) 2.62
Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior. Clin Exp Metastasis (2005) 2.52
Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav Immun (2008) 2.50
Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun (2010) 2.44
Comparison of polychlorinated biphenyl levels across studies of human neurodevelopment. Environ Health Perspect (2003) 2.41
Concern The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. Eur J Gastroenterol Hepatol (2005) 2.41
Arsenic exposure from drinking water and birth weight. Epidemiology (2003) 2.32
Consensus paper: pathological role of the cerebellum in autism. Cerebellum (2012) 2.32
Attenuation of exposure-response curves in occupational cohort studies at high exposure levels. Scand J Work Environ Health (2003) 2.27
The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun (2011) 2.24
Traffic-related air pollution, particulate matter, and autism. JAMA Psychiatry (2013) 2.24
Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab (2006) 2.20
Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics (2012) 2.18
Heme and iron metabolism: role in cerebral hemorrhage. J Cereb Blood Flow Metab (2003) 2.16
Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study. Am J Clin Nutr (2012) 2.14
In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis. J Neurosci (2002) 2.12
Mitochondrial dysfunction in autism. JAMA (2010) 2.04
Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J Exp Med (2002) 2.00
Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse. FASEB J (2005) 1.97
Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse. Anesthesiology (2006) 1.97
Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration. Hum Mol Genet (2010) 1.95
Hypoxia-ischemia induces DNA synthesis without cell proliferation in dying neurons in adult rodent brain. J Neurosci (2004) 1.94
Residential proximity to freeways and autism in the CHARGE study. Environ Health Perspect (2010) 1.92
The faroes statement: human health effects of developmental exposure to chemicals in our environment. Basic Clin Pharmacol Toxicol (2008) 1.91
Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochem Biophys Res Commun (2008) 1.89
Autism: maternally derived antibodies specific for fetal brain proteins. Neurotoxicology (2007) 1.87
Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun (2009) 1.86
The human placenta methylome. Proc Natl Acad Sci U S A (2013) 1.86
Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor. J Clin Oncol (2004) 1.85
Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer. Clin Cancer Res (2002) 1.82
In vitro biologic activities of the antimicrobials triclocarban, its analogs, and triclosan in bioassay screens: receptor-based bioassay screens. Environ Health Perspect (2008) 1.82
Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch Pediatr Adolesc Med (2005) 1.81
Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav Immun (2008) 1.79
Coordinated movement of cytoplasmic and transmembrane domains of RyR1 upon gating. PLoS Biol (2009) 1.77
Prediction of cardioembolic, arterial, and lacunar causes of cryptogenic stroke by gene expression and infarct location. Stroke (2012) 1.77
Identification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood. BMC Med Genomics (2009) 1.73
Sleep problems in children with autism spectrum disorders, developmental delays, and typical development: a population-based study. J Sleep Res (2008) 1.72
Indoor coal use and early childhood growth. Arch Pediatr Adolesc Med (2011) 1.71
Self-reported heavy bleeding associated with uterine leiomyomata. Obstet Gynecol (2003) 1.68
Low-level neonatal thimerosal exposure: further evaluation of altered neurotoxic potential in SJL mice. Toxicol Sci (2007) 1.68
Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells. Mol Endocrinol (2005) 1.67
NADH oxidase activity of rat cardiac sarcoplasmic reticulum regulates calcium-induced calcium release. Circ Res (2003) 1.67
Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest (2002) 1.65
Epidemiologic measures of the course and outcome of pregnancy. Epidemiol Rev (2002) 1.62
Mercury methylation from unexpected sources: molybdate-inhibited freshwater sediments and an iron-reducing bacterium. Appl Environ Microbiol (2006) 1.61
Gene expression profiling of blood for the prediction of ischemic stroke. Stroke (2010) 1.61
Psychosocial factors and preterm birth among African American and White women in central North Carolina. Am J Public Health (2004) 1.60
Aryl hydrocarbon receptor signaling regulates NF-κB RelB activation during dendritic-cell differentiation. Immunol Cell Biol (2013) 1.60
A new look at XXYY syndrome: medical and psychological features. Am J Med Genet A (2008) 1.59
Ablation of triadin causes loss of cardiac Ca2+ release units, impaired excitation-contraction coupling, and cardiac arrhythmias. Proc Natl Acad Sci U S A (2009) 1.57
Regression in autism: prevalence and associated factors in the CHARGE Study. Ambul Pediatr (2008) 1.56
Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Ann N Y Acad Sci (2007) 1.55
Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology (2009) 1.55
Gene expression changes in children with autism. Genomics (2007) 1.55
Enhanced excitation-coupled calcium entry in myotubes expressing malignant hyperthermia mutation R163C is attenuated by dantrolene. Mol Pharmacol (2008) 1.55
Glutamate receptor blockade attenuates glucose hypermetabolism in perihematomal brain after experimental intracerebral hemorrhage in rat. Stroke (2004) 1.54
Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study. Biol Psychiatry (2008) 1.54
Neurodevelopmental disorders and prenatal residential proximity to agricultural pesticides: the CHARGE study. Environ Health Perspect (2014) 1.54
Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology (2010) 1.53
The onset of autism: patterns of symptom emergence in the first years of life. Autism Res (2008) 1.53
Altered T cell responses in children with autism. Brain Behav Immun (2010) 1.53
Brain genomic response following hypoxia and re-oxygenation in the neonatal rat. Identification of genes that might contribute to hypoxia-induced ischemic tolerance. J Biol Chem (2002) 1.52
Geldanamycin induces heat shock proteins in brain and protects against focal cerebral ischemia. J Neurochem (2002) 1.52
Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study. Mol Autism (2011) 1.51